1,918 research outputs found

    The utility of efavirenz-based prophylaxis against HIV infection. A systems pharmacological analysis

    Get PDF
    Pre-exposure prophylaxis (PrEP) is considered one of the five “pillars” by UNAIDS to reduce HIV transmission. Moreover, it is a tool for female self-protection against HIV, making it highly relevant to sub-Saharan regions, where women have the highest infection burden. To date, Truvada is the only medication for PrEP. However, the cost of Truvada limits its uptake in resource-constrained countries. Similarly, several currently investigated, patent-protected compounds may be unaffordable in these regions. We set out to explore the potential of the patent-expired antiviral efavirenz (EFV) as a cost-efficient PrEP alternative. A population pharmacokinetic model utilizing data from the ENCORE1 study was developed. The model was refined for metabolic autoinduction. We then explored EFV cellular uptake mechanisms, finding that it is largely determined by plasma protein binding. Next, we predicted the prophylactic efficacy of various EFV dosing schemes after exposure to HIV using a stochastic simulation framework. We predicted that plasma concentrations of 11, 36, 1287 and 1486ng/mL prevent 90% sexual transmissions with wild type and Y181C, K103N and G190S mutants, respectively. Trough concentrations achieved after 600 mg once daily dosing (median: 2017 ng/mL, 95% CI:445–9830) and after reduced dose (400 mg) efavirenz (median: 1349ng/mL, 95% CI: 297–6553) provided complete protection against wild-type virus and the Y181C mutant, and median trough concentrations provided about 90% protection against the K103N and G190S mutants. As reduced dose EFV has a lower toxicity profile, we predicted the reduction in HIV infection when 400 mg EFV-PrEP was poorly adhered to, when it was taken “on demand” and as post-exposure prophylaxis (PEP). Once daily EFV-PrEP provided 99% protection against wild-type virus, if ≄50% of doses were taken. PrEP “on demand” provided complete protection against wild-type virus and prevented ≄81% infections in the mutants. PEP could prevent >98% infection with susceptible virus when initiated within 24 h after virus exposure and continued for at least 9 days. We predict that 400 mg oral EFV may provide superior protection against wild-type HIV. However, further studies are warranted to evaluate EFV as a cost-efficient alternative to Truvada. Predicted prophylactic concentrations may guide release kinetics of EFV long-acting formulations for clinical trial design

    CRISPR-Based Methods for Caenorhabditis elegans Genome Engineering

    Get PDF
    The advent of genome editing techniques based on the clustered regularly interspersed short palindromic repeats (CRISPR)–Cas9 system has revolutionized research in the biological sciences. CRISPR is quickly becoming an indispensible experimental tool for researchers using genetic model organisms, including the nematode Caenorhabditis elegans. Here, we provide an overview of CRISPR-based strategies for genome editing in C. elegans. We focus on practical considerations for successful genome editing, including a discussion of which strategies are best suited to producing different kinds of targeted genome modifications

    The Stellar Masses and Star Formation Histories of Galaxies at z ≈ 6: Constraints from Spitzer Observations in the Great Observatories Origins Deep Survey

    Get PDF
    Using the deep Spitzer Infrared Array Camera (IRAC) observations of the Great Observatories Origins Deep Survey (GOODS), we study the stellar masses and star formation histories of galaxies at z approx 6 based on the i_(775)-band dropout sample selected from the GOODS fields. In total, we derive stellar masses for 53 i_(775)-band dropouts that have robust IRAC detections. These galaxies have typical stellar masses of ~10^(10) M_⊙ and typical ages of a couple of hundred million years, consistent with earlier results based on a smaller sample of z ≈ 6 galaxies. The existence of such massive galaxies at z ≈ 6 can be explained by at least one set of N-body simulations of the hierarchical paradigm. We also study 79 i_(775)-band dropouts that are invisible in the IRAC data and find that they are typically less massive by a factor of 10. These galaxies are much bluer than those detected by the IRAC, indicating that their luminosities are dominated by stellar populations with ages ≟ 40 Myr. Based on our mass estimates, we derive a lower limit to the global stellar mass density at z ≈ 6, which is 1.1-6.7 × 10^6 M_⊙ Mpc^(-3). The prospect of detecting the progenitors of the most massive galaxies at yet higher redshifts is explored. We also investigate the implication of our results for reionization and find that the progenitors of the galaxies comparable to those in our sample, even in the most optimized (probably unrealistic) scenario, cannot sustain the reionization for a period longer than ~2 Myr. Thus most of the photons required for reionization must have been provided by other sources, such as the progenitors of the dwarf galaxies that are far below our current detection capability

    z ~ 4 Hα Emitters in the Great Observatories Origins Deep Survey: Tracing the Dominant Mode for Growth of Galaxies

    Get PDF
    We present evidence for strong Hα emission in galaxies with spectroscopic redshifts in the range of 3.8 10^(11) M_☉) galaxies at z ~ 3. This "strong Hα phase" of star formation plays a dominant role in galaxy growth at z ~ 4, and they are likely progenitors of massive red galaxies at lower redshifts

    Measuring Protein Binding to F-actin by Co-sedimentation

    Get PDF
    Filamentous actin (F-actin) organization within cells is regulated by a large number of actin-binding proteins that control actin nucleation, growth, cross-linking and/or disassembly. This protocol describes a technique – the actin co-sedimentation, or pelleting, assay – to determine whether a protein or protein domain binds F-actin and to measure the affinity of the interaction (i.e., the dissociation equilibrium constant). In this technique, a protein of interest is first incubated with F-actin in solution. Then, differential centrifugation is used to sediment the actin filaments, and the pelleted material is analyzed by SDS-PAGE. If the protein of interest binds F-actin, it will co-sediment with the actin filaments. The products of the binding reaction (i.e., F-actin and the protein of interest) can be quantified to determine the affinity of the interaction. The actin pelleting assay is a straightforward technique for determining if a protein of interest binds F-actin and for assessing how changes to that protein, such as ligand binding, affect its interaction with F-actin

    Solid-state synthesis of embedded single-crystal metal oxide and phosphate nanoparticles and in situ crystallization

    Get PDF
    A new solid state organometallic route to embedded nanoparticle-containing inorganic materials is shown, through pyrolysis of metal-containing derivatives of cyclotriphosphazenes. Pyrolysis in air and at 800 °C of new molecular precursors gives individual single-crystal nanoparticles of SiP2O7, TiO2, P4O7, WP2O7 and SiO2, depending on the precursor used. High resolution transmission electron microscopy investigations reveal, in most cases, perfect single crystals of metal oxides and the first nanostructures of negative thermal expansion metal phosphates with diameters in the range 2–6 nm for all products. While all nanoparticles are new by this method, WP2O7 and SiP2O7 nanoparticles are reported for the first time. In situ recrystallization formation of nanocrystals of SiP2O7 was also observed due to electron beam induced reactions during measurements of the nanoparticulate pyrolytic products SiO2 and P4O7. The possible mechanism for the formation of the nanoparticles at much lower temperatures than their bulk counterparts in both cases is discussed. Degrees of stabilization from the formation of P4O7 affects the nanocrystalline products: nanoparticles are observed for WP2O7, with coalescing crystallization occurring for the amorphous host in which SiP2O7 crystals form as a solid within a solid. The approach allows the simple formation of multimetallic, monometallic, metal-oxide and metal phosphate nanocrystals embedded in an amorphous dielectric. The method and can be extended to nearly any metal capable of successful coordination as an organometallic to allow embedded nanoparticle layers and features to be deposited or written on surfaces for application as high mobility pyrophosphate lithium–ion cathode materials, catalysis and nanocrystal embedded dielectric layers
    • 

    corecore